TAF6-Like RNA Polymerase II, P300/CBP-Associated Factor (PCAF)-Associated Factor, 65kDa (TAF6L) Peptide
-
- Target See all TAF6L products
- TAF6L (TAF6-Like RNA Polymerase II, P300/CBP-Associated Factor (PCAF)-Associated Factor, 65kDa (TAF6L))
- Origin
- Human, Rat, Mouse
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-TAF6L Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- TAF6L (TAF6-Like RNA Polymerase II, P300/CBP-Associated Factor (PCAF)-Associated Factor, 65kDa (TAF6L))
- Synonyms
- MGC80584 Peptide, TAF6L Peptide, 2810417N14Rik Peptide, BB223262 Peptide, C530024J06Rik Peptide, Paf65a Peptide, PAF65A Peptide, TATA-box binding protein associated factor 6 like S homeolog Peptide, TATA-box binding protein associated factor 6 like Peptide, taf6l.S Peptide, TAF6L Peptide, Taf6l Peptide
- Background
- PAF65A, TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L, PCAF-associated factor 65-alpha, PAF65-alpha
- Gene ID
- 10629, 225895
- UniProt
- Q9Y6J9, Q8R2K4
-